The efficacy of DW-F5 to disarray the above-mentioned signaling axis operating in melanoma cells is demonstrated in its ability to down-regulate constitutive as well as induced activation of ERK1/2, Akt, NF-κB, COX-2 and Bcl-2. This evidence concerns the gene BCL2 and melanoma.